✨ Your Portfolio is fetched and updated from zerodha.
Micro Pharmaceuticals

Valiant Laboratories Ltd.

VALIANTLAB

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹451 Cr.
P/E
0.00

Valiant Laboratories Ltd.

Key Ratios

Edit Ratio's
Market cap
Market cap
451 Cr
PE
PE
-
Prom Holding
Prom Holding
74.94 %
ROE (%)
ROE (%)
-0.94
ROCE (%)
ROCE (%)
-0.39
Div Yield (%)
Div Yield (%)
-
Sales
Sales
161 Cr
OPM (%)
OPM (%)
0.07 %
Debt to Equity
Debt to Equity
0.52
View more
Edit Ratio's

About

Valiant Laboratories is in the Pharmaceuticals sector with a M.cap of 451.00 Cr and a … Read more
Low
70
52W Range
High
121
  • Valiant Laboratories
  • Influx Healthtech
  • Amanta Healthcare

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Company Timeline

Subscribe now for more updates

Custom financial statement

New
Edit rows

Forensics

5 Yes

Positive for this company

3 Neutral

Neutral for this company

5 No

Negative for this company

4 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Asset Break-Up - Geography Wise

Peer Comparison

Corporate Actions

Consolidated
DATE
DETAILS
Show More
Show Less
Show More
Show Less

FAQs on Valiant Laboratories Ltd. Business

NA

Valiant Laboratories major competitors are Influx Healthtech, Amanta Healthcare, Medico Remedies, Albert David, Gennex Lab, Medicamen Biotech, Kerala Ayurveda.
Market Cap of Valiant Laboratories is ₹451 Crs.
While the median market cap of its peers are ₹474 Crs.

Valiant Laboratories seems to be less financially stable compared to its competitors.
Altman Z score of Valiant Laboratories is 2.92 and is ranked 6 out of its 8 competitors.

View FAQ's On Shareprice

Company Filing

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Annual Report FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
Earnings Release
Investor Presentation
Conference Call
Conference Call SummaryCon Call Summary

Discussions & Analysis

Pharmaceuticals
How The Pharma Industry Works - PPFAS
Deep Dive into Pharma Sector - Omkara Capital
Pharma Compliance In-Depth - Amit Rajan
Nutraceuticals - The Next Gem of Healthcare Sector - Shuchi Nahar
Nutraceuticals- Industry Overview - Value Educator
GLP-1: The Drug Redefining Diabetes, Obesity, and Pharma’s Future - Perpetuity
Generic Opportunity for Indian Pharma Companies - Anish Moonka
Understanding the CDMO Sector - Will It Be The Next Megatrend - SOIC
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material